Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Risteli

Showing results (161-170 of 209) with videos related to

Pageof 21
Sort By:
Cancer Research|January 4, 1998
Aggressive breast cancer leads to discrepant serum levels of the type I procollagen propeptides PINP and PICPA Jukkola, R Tähtelä, E Thölix, et al.
The Journal of Pediatrics|February 1, 1989
Growth velocity, growth hormone therapy, and serum concentrations of the amino-terminal propeptide of type III procollagenP Trivedi, P Hindmarsh, J Risteli, et al.
Circulation|June 1, 1991
Thrombolytic therapy with streptokinase stimulates collagen breakdownK J Peuhkurinen, L Risteli, J T Melkko, et al.
European Journal of Clinical Investigation|December 1, 1994
Serum ionized calcium, intact PTH and novel markers of bone turnover in bedridden elderly patientsA Sorva, M Välimäki, J Risteli, et al.
The British Journal of Dermatology|January 1, 1997
Increased levels of type I and III collagen and hyaluronan in scleroderma skinK Søndergaard, L Heickendorff, L Risteli, et al.
Pediatric Research|May 1, 1993
Clinical characteristics and circulating collagen and laminin metabolites in insulin-dependent diabetic children with joint and skin manifestationsR Veijola, M Knip, L Risteli, et al.
Archives of Dermatological Research|January 1, 1995
Increased collagen synthesis in psoriasis in vivoV Koivukangas, M Kallionen, J Karvonen, et al.
Pediatric Research|October 1, 1995
Prognostic value of serum hyaluronic acid and type I and III procollagen propeptides in extrahepatic biliary atresiaP Trivedi, A Dhawan, J Risteli, et al.
Bone|March 17, 2000
Immunochemical characterization of assay for carboxyterminal telopeptide of human type I collagen: loss of antigenicity by treatment with cathepsin KM L Sassi, H Eriksen, L Risteli, et al.
European Journal of Clinical Investigation|September 1, 1996
Effects of low- and conventional-dose transcutaneous HRT over 2 years on bone metabolism in younger and older postmenopausal womenC A Sharp, S F Evans, L Risteli, et al.
Pageof 21

Showing results (161-170 of 209) with videos related to

Sort By:
Pageof 21
Cancer Research|January 4, 1998
Aggressive breast cancer leads to discrepant serum levels of the type I procollagen propeptides PINP and PICPA Jukkola, R Tähtelä, E Thölix, et al.
The Journal of Pediatrics|February 1, 1989
Growth velocity, growth hormone therapy, and serum concentrations of the amino-terminal propeptide of type III procollagenP Trivedi, P Hindmarsh, J Risteli, et al.
Circulation|June 1, 1991
Thrombolytic therapy with streptokinase stimulates collagen breakdownK J Peuhkurinen, L Risteli, J T Melkko, et al.
European Journal of Clinical Investigation|December 1, 1994
Serum ionized calcium, intact PTH and novel markers of bone turnover in bedridden elderly patientsA Sorva, M Välimäki, J Risteli, et al.
The British Journal of Dermatology|January 1, 1997
Increased levels of type I and III collagen and hyaluronan in scleroderma skinK Søndergaard, L Heickendorff, L Risteli, et al.
Pediatric Research|May 1, 1993
Clinical characteristics and circulating collagen and laminin metabolites in insulin-dependent diabetic children with joint and skin manifestationsR Veijola, M Knip, L Risteli, et al.
Archives of Dermatological Research|January 1, 1995
Increased collagen synthesis in psoriasis in vivoV Koivukangas, M Kallionen, J Karvonen, et al.
Pediatric Research|October 1, 1995
Prognostic value of serum hyaluronic acid and type I and III procollagen propeptides in extrahepatic biliary atresiaP Trivedi, A Dhawan, J Risteli, et al.
Bone|March 17, 2000
Immunochemical characterization of assay for carboxyterminal telopeptide of human type I collagen: loss of antigenicity by treatment with cathepsin KM L Sassi, H Eriksen, L Risteli, et al.
European Journal of Clinical Investigation|September 1, 1996
Effects of low- and conventional-dose transcutaneous HRT over 2 years on bone metabolism in younger and older postmenopausal womenC A Sharp, S F Evans, L Risteli, et al.
Pageof 21